Costs for lifesaving drugs have skyrocketed. Experts say ‘over-patenting’ to prevent generic competition is part of the problem
Examining the Truvada #BreakThePatent Debate: Gilead Responds
Why Abbvie May Have A Tough Time Defending Humira’s Price Before Congress
It’s Time for Pharmaceutical Companies to Have Their Tobacco Moment
Bringing the medicine access fight to the US
Beyond “Capacity Building”: Crafting Partnerships Based on Equality
Public Participation in the Patent System Will Lower Drug Costs
How High-Priced Drugs Cripple Prison Health Care—and Reform
Patent abuse is driving up drug prices. Just look at Lantus
Wall Street Wants the Best Patents, Not the Best Drugs